ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstracts tagged "meloxicam"

  • Abstract Number: 2359 • ACR/ARHP Annual Meeting 2016

    Dose-Related Risks of Cardiovascular, Gastrointestinal, and Renal Adverse Events Associated with Meloxicam Among Patients with Osteoarthritis: An Observational Study Using US Claims Data

    Elaine Hoffman1, Deirdre M. Mladsi1, Byron Cryer2, William Hopkins3, D. Craig Brater4, Rohan Parikh1, Ravi Goyal1, Jordi Castellsague5, Dana Stafkey-Mailey6 and Clarence Young7, 1Health Economics, RTI Health Solutions, Research Triangle Park, NC, 2University of Texas Southwestern Medical School, Dallas, TX, 3Fletcher Allen Health Care, University of Vermont College of Medicine, Burlington, VT, 4Indiana University School of Medicine, Bloomington, IN, 5Epidemiology, RTI Health Solutions, Barcelona, Spain, 6Xcenda, AmerisourceBergen, Palm Harbor, FL, 7Iroko Pharmaceuticals, LLC, Philadelphia, PA

    Background/Purpose:  Safety studies have shown that risks associated with non-steroidal anti-inflammatory drugs (NSAIDs) are related to dose; however, there is little evidence regarding this dose-toxicity…
Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology